Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT
(2023)
Journal Article
Donoghue, K., Boniface, S., Brobbin, E., Byford, S., Coleman, R., Coulton, S., …Drummond, C. (2023). Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT. Health Technology Assessment, 27(22), 1-88. https://doi.org/10.3310/DQKL6124
Background: Acamprosate is an effective and cost-effective medication for alcohol relapse prevention but poor adherence can limit its full benefit. Effective interventions to support adherence to acamprosate are therefore needed. Objectives: To deter... Read More about Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT.